Form 4: Progyny Executive Sells Shares for Tax Withholding

Progyny's Executive Chairman, David J. Schlanger, disposed of 2,171 common shares at $25.68 each to cover tax obligations from restricted stock unit vesting.

Summary

• David J. Schlanger, Executive Chairman and Director of Progyny, Inc. (PGNY), reported a transaction on January 2, 2026.
• The transaction involved the disposition of 2,171 shares of Progyny Common Stock.
• These shares were withheld for the payment of withholding taxes upon the vesting of restricted stock units granted to Mr. Schlanger.
• The shares were disposed of at a price of $25.68 per share.
• Following this transaction, Mr. Schlanger beneficially owns 238,462 shares of Progyny Common Stock directly.

Sentiment

Score: 5

Explanation: The filing reports a routine insider transaction for tax withholding purposes upon RSU vesting, which is a standard practice and does not indicate positive or negative sentiment regarding the company's performance or prospects.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding Progyny, Inc.'s future outlook.

Industry Context

This is a routine insider transaction (Form 4) related to tax withholding upon RSU vesting, which is common across all publicly traded companies and does not reflect specific industry trends or competitive dynamics within the fertility benefits sector.

Comparison to Industry Standards

• This type of transaction, where shares are withheld to cover tax liabilities upon the vesting of restricted stock units, is a standard practice for executive compensation across various industries and is not unique to Progyny or its specific sector. It aligns with typical compensation structures involving equity awards.

Stakeholder Impact

• Shareholders: Minimal direct impact as this is a routine, non-discretionary transaction for tax purposes, not a market sale driven by a change in investment thesis.
• Employees: No direct impact on the broader employee base.
• Customers, Suppliers, Creditors: No direct impact.

Key Dates

Keywords

Progyny, PGNY, David J. Schlanger, Insider Transaction, Form 4, Restricted Stock Units, Tax Withholding, Executive Chairman, Director, Stock Sale